Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Breast Neoplasms 4 Pancreatic Neoplasms 3 Lung Neoplasms 3 Urinary Bladder Neoplasms 2 Melanoma 2 Carcinoma, Renal Cell 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Spinal Cord Diseases 1 Spinal Cord Compression 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Prostate Cancer Metastatic Disease 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 Lymphatic Metastasis 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Epidural Neoplasms 1

Interventions

pembrolizumab 16 Bevacizumab 12 Carboplatin 10 Nivolumab 8 Pemetrexed 7 Temozolomide 6 Standard of Care 6 Exercise 6 Cetuximab 6 durvalumab 5 atezolizumab 5 Prednisone 5 Cyclophosphamide 5 abemaciclib 4 Paclitaxel 4 Doxorubicin 4 Dexamethasone 4 Cisplatin 4 Blood Specimen Collection 4 temsirolimus 3 enzalutamide 3 dostarlimab 3 daratumumab 3 cabozantinib 3 Sunitinib 3 Rituximab 3 Oxaliplatin 3 Metformin 3 Leucovorin 3 Lenalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Radiosurgery × 30 days × Clear all

NCT04122469 2026-06-04

RADIANT

University Health Network, Toronto

Phase NA Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡